Labcorp offers at-home collection kits for COVID-19 testing as an alternative to physical testing centers. Learn more about the company and the at-home collection process here.

Labcorp is paying $192.5 million for the oncology testing business of BioReference, according to financial terms announced ...

Laboratory Corporation of America Holdings or Labcorp LH recently introduced a screening test for preeclampsia in the first trimester, which will be done between weeks 11 and 14 of pregnancy to ...

Express Diagnostics Int’l Inc.'s first-ever onsite lateral flow test, for ethyl glucuronide (EtG), a unique biomarker of alcohol use, the new DrugCheck Rapid EtG urine test ...

Laboratory Corporation of America Holdings, Inc., or Labcorp LH, recently launched a new, FDA-cleared blood test for risk assessment and clinical management of severe preeclampsia. The ...

RESEARCH TRIANGLE PARK – Burlington-based Labcorp has begun selling the first widely accessible test for direct evidence of neurodegeneration and neuronal injury. The new Neurofilament Light ...

Labcorp on Wednesday began marketing to U.S. physicians the first test for a trio of blood biomarkers it says can detect the hallmarks of Alzheimer's, accelerating diagnosis of the brain-wasting ...

Plasma Focus represents the first new test to come out of Labcorp’s acquisition of Personal Genome Diagnostics. The buyout closed in February 2022 and saw Labcorp offer up $450 million in ...

Labcorp is rolling out a new test that will allow doctors to "identify and verify" signs of neurogenerative disease such as Alzheimer's and Parkinson's, the North Carolina-based life science giant ...

The company attributed the lower revenue to a decrease in Covid-19 testing. LabCorp’s net income for the quarter was $358.6 million, down 23.2% compared to the second quarter of 2021.

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests.. Labcorp is paying $192.5 million ...